Australia markets closed

iTeos Therapeutics, Inc. (ITOS)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
11.66+0.17 (+1.48%)
At close: 04:00PM EDT
11.66 0.00 (0.00%)
After hours: 04:03PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
454,229
12,595
267,630
344,775
0
Operating expenses
Research development
89,324
113,300
97,359
59,369
29,900
Selling general and administrative
42,444
50,396
43,947
40,505
15,340
Total operating expenses
128,929
157,482
138,043
89,693
39,307
Operating income or loss
325,300
-144,887
129,587
255,082
-39,307
Total other income/expenses net
24,734
4,083
7,788
1,304
1,217
Income before tax
350,034
-109,030
148,736
256,464
-38,090
Income tax expense
88,963
3,612
52,084
41,943
-57
Income from continuing operations
261,071
-112,642
96,652
214,521
-38,033
Net income
261,071
-112,642
96,652
214,521
-38,033
Net income available to common shareholders
261,071
-112,642
96,652
214,521
-43,402
Basic EPS
-1.72
-
2.72
6.10
-2.88
Diluted EPS
-1.75
-
2.56
5.68
-2.88
Basic average shares
35,715
-
35,552
35,181
15,080
Diluted average shares
36,195
-
37,767
37,775
15,080